Visceral fat is the fat that accumulates around internal organs. It is metabolically distinct from subcutaneous fat: it is more inflammatory, more closely linked to insulin resistance, and more resistant to diet and exercise than the fat you can see or pinch. Tesamorelin works upstream of that problem. As a growth hormone-releasing hormone analog, it prompts your own pituitary to release growth hormone, which raises IGF-1 and, in studies, reduces visceral adipose tissue. At AgeRejuvenation it is evaluated against your full hormonal and metabolic picture before any protocol is built.
At AgeRejuvenation, tesamorelin is prescribed against your labs, not as a one-size protocol. We start with a full hormonal and metabolic workup, confirm how your growth hormone and IGF-1 axis is functioning, then supervise dosing with follow-up bloodwork. This guide explains what tesamorelin is, who it may suit, how it works on visceral fat, the benefits and real risks, how it compares with similar peptides, what monitoring involves, and what treatment costs.
What Is Tesamorelin?
Answer: Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that prompts the pituitary gland to release growth hormone, raising IGF-1 and reducing visceral fat. It works through your own pituitary pathway rather than injecting synthetic growth hormone directly.
The mechanism follows a clear cascade. Tesamorelin binds to GHRH receptors in the pituitary, which increases natural growth hormone secretion. That growth hormone signals the liver to produce IGF-1, and elevated IGF-1 then acts on adipose tissue and metabolic processes throughout the body. Because the pituitary keeps its own feedback loop intact, the system self-moderates when growth hormone reaches an appropriate level, avoiding the runaway elevation that direct synthetic HGH can cause. The National Institute on Aging describes how growth hormone and IGF-1 change with aging and shape body composition over time.
How Does Tesamorelin Work on Visceral Fat?
Answer: Tesamorelin reduces visceral fat indirectly by restoring the growth hormone and IGF-1 signaling that normally keeps deep abdominal fat in check, rather than targeting fat cells directly the way a stimulant or surgery would.
Visceral fat sits around the internal organs and is metabolically active, releasing inflammatory signals and contributing to insulin resistance. Cleveland Clinic explains the role of visceral fat in metabolic and cardiovascular risk and why it behaves differently from the fat under your skin. By lifting the growth hormone and IGF-1 axis, tesamorelin addresses the hormonal environment that decides where the body stores fat, which is why it is studied specifically for stubborn visceral accumulation that diet and exercise leave behind.
Who Is a Candidate for Tesamorelin?
Answer: Good candidates are adults with stubborn visceral fat, age-related growth hormone decline, or unfavorable body composition who have completed a workup confirming the GHRH pathway is the right lever, and who can commit to daily injections and ongoing monitoring.
Tesamorelin is not a first stop for general weight loss, and it is not for everyone. Candidacy depends on your hormone panel, metabolic markers, and medical history, and it is evaluated alongside our broader weight loss and body composition services. People with active cancer, certain pituitary conditions, or who are pregnant or breastfeeding are not candidates, which is one reason a physician review before any prescription is non-negotiable.
What Are the Benefits of Tesamorelin?
Answer: The most studied benefit is reduction of visceral adipose tissue, with supporting effects on lean body composition, fat distribution, and the growth hormone and IGF-1 axis that declines with age. Cognitive benefits are an emerging, secondary area of research.
For patients who have already trimmed overall body fat through lifestyle change but still carry deep abdominal fat, tesamorelin targets the upstream driver rather than asking for more restriction. Because it works through the pituitary, it preserves the body's natural feedback controls, which many patients and clinicians view as a meaningful advantage over direct HGH. The size of any benefit depends on accurate dosing and consistent follow-up, which is where supervised care separates from an unmonitored protocol.
What Are the Side Effects and Risks?
Answer: Most reported side effects are mild and dose-related: injection-site redness, fluid retention, joint or muscle aches, and tingling or numbness in the hands. Because tesamorelin raises IGF-1, supervised dosing and periodic bloodwork are essential.
Elevated IGF-1 is the reason monitoring is not optional. Your provider checks IGF-1 at baseline and at intervals so the dose stays in a safe range, and tesamorelin is generally avoided in people with active malignancy. The U.S. Food and Drug Administration maintains the approved prescribing information for tesamorelin, which details the studied safety profile. Like any peptide that influences a hormonal axis, tesamorelin is never set and forget; it is dosed from labs and rechecked over time.
Tesamorelin vs. Sermorelin vs. CJC-1295
Answer: All three are growth hormone-supporting peptides that work through the GHRH pathway, but they differ in how long they act and what they are best studied for. Tesamorelin has the most concentrated data on visceral fat reduction.
| Peptide | How it works | Acting profile | Best studied for |
|---|---|---|---|
| Tesamorelin | GHRH analog, stimulates pituitary GH release | Longer-acting, daily | Visceral fat reduction, body composition |
| Sermorelin | GHRH analog, stimulates pituitary GH release | Shorter-acting, daily | General growth hormone optimization |
| CJC-1295 | Long-acting GHRH analog | Extended half-life | Sustained GH and IGF-1 support |
The right peptide is the one that matches your goals, labs, and tolerance, and the choice is made at evaluation rather than from a menu. We do not stack concurrent GHRH analogs without clinical review, and your protocol can change as your bloodwork evolves.
What Does a Tesamorelin Protocol Involve?
Answer: A typical protocol is a daily subcutaneous injection, usually in the evening, paired with IGF-1 testing at baseline and at intervals so dosing stays accurate. Duration is individualized to your response and goals.
Treatment begins with a full hormonal and metabolic workup, because growth hormone, IGF-1, thyroid, testosterone, and metabolic markers all interact. The U.S. National Library of Medicine offers a plain-language overview of how growth hormone functions in the body, which helps explain why we look at the whole axis rather than a single number. From there we set a starting dose, recheck IGF-1, and adjust, tracking visceral fat with waist measurements and sometimes imaging over the first few months.
How Does Tesamorelin Differ From HGH?
Answer: Tesamorelin stimulates your own pituitary to make growth hormone, so the body's feedback loop stays active. Synthetic HGH delivers the hormone directly, bypassing that control and the natural ceiling the pituitary normally enforces.
That difference matters for safety. With tesamorelin, when growth hormone reaches an appropriate level the system moderates itself, which reduces the risk of the sustained overexposure that direct HGH can create. It is one reason GHRH analogs are increasingly preferred for age-related growth hormone support when used under supervision and lab monitoring.
How Much Does Tesamorelin Therapy Cost?
Answer: Tesamorelin is typically self-pay because it falls outside standard insurance coverage, and the monthly cost varies with dosing, duration, and the lab work your plan requires.
Because plans are individual, we review the full cost, including baseline and follow-up bloodwork, before you begin, so there are no surprises. The aim is a plan you can sustain long enough to see a real change in body composition, since the visceral fat effect builds over months of consistent dosing rather than in a single visit.
Why Choose AgeRejuvenation for Tesamorelin?
Answer: Tesamorelin done well is built on a complete hormonal picture and ongoing IGF-1 monitoring, not a single prescription. Our physician-led team supervises every protocol against your individual lab data.
Clinical direction is led by Dr. Dawn Ericsson, MD, alongside a team experienced in peptide and hormone optimization across our Florida clinics serving Tampa Bay and Orlando. We measure IGF-1 before you start and at intervals, adjust from your results, and explain what your numbers mean so you stay a partner in your care. Tesamorelin is one option within our broader wellness and metabolic program, which also includes sermorelin, CJC-1295, and other individually evaluated peptides. One comprehensive baseline can change how the next several months feel.
Explore more in our wellness center services .
